StreetAlpha.app
Home › Stocks › DVA

Davita Inc. (DVA)

Healthcare
$173.07
▼ −0.59%
LAST CLOSE · NOV 17

DaVita provides kidney dialysis and kidney care services to patients with kidney failure, mainly in the United States. It last closed at $173.07 on Nov 17, down 0.59% on the day. DVA reports earnings on Mon, Feb 1, 2027. The average 12-month price target from 3 analysts is $243.67 (+40.8% from the last close), with a high of $287.00 and a low of $216.00. Analyst consensus is Buy, based on the latest ratings from 3 firms (2 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in DVA, 25% of them bullish and 75% bearish. In the past 30 days there were 3 dark pool prints totaling $2.1M, the largest $915K.

AI Auto Pilots
Is DVA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$14.2B
+6.4% vs a year ago
Net income
$920.1M
+19.2% vs a year ago
EPS (diluted)
$13.49
+39.2% vs a year ago
Free cash flow
$1.3B
9.1% margin
Valuation
Market cap
$10.9B
62.9M shares
P/E
12.8
Price over 12 month EPS
Price to sales
0.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$495.6M
At Sep 30
Shareholder equity
−$591.1M
Buybacks
$725.3M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $11.6B$11.6BFY2021FY2022: $11.6B$11.6BFY2022FY2023: $12.1B$12.1BFY2023FY2024: $12.8B$12.8BFY2024FY2025: $13.6B$13.6BFY2025

From DVA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 1
2027 · Time not announced
Consensus EPS forecast
$4.14
$3.65B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
3firms
2 Buy1 Hold0 Sell
Each firm's latest rating on DVA in the past 90 days
Average 12-month target
$243.67
▲ 40.8% upside

Based on 3 analysts who set a price target on DVA in the past 90 days. The average target is $243.67, with a high of $287.00 and a low of $216.00, compared with the last close of $173.07.

$164$208$252$296PAST 10 TRADING DAYS12-MONTH TARGETSHIGH $287AVG $243.67LOW $216Jun 17LAST CLOSE+12 MO$164$208$252$296PAST 10 DAYSTARGETSHIGH $287AVG $243.67LOW $216Jun 17LAST CLOSE+12 MO
Highest target$287.00
Average target$243.67
Lowest target$216.00
Latest rating changes
UBSTarget raised
Nov 2Buy$270 → $287
BarclaysTarget lowered
Nov 2Hold$224 → $216
TD CowenTarget raised
Nov 2Buy$220 → $228
TD CowenUpgrade
Aug 7Buy$220
Truist SecuritiesTarget lowered
Aug 7Hold$250 → $215
DateFirmActionRatingPrice target
Nov 2UBSTarget raisedBuy$270 → $287
Nov 2BarclaysTarget loweredHold$224 → $216
Nov 2TD CowenTarget raisedBuy$220 → $228
Aug 7TD CowenUpgradeBuy$220
Aug 7Truist SecuritiesTarget loweredHold$250 → $215
Loading…

Technical Analysis

DVA · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend

The stock is 6% below its 20 day and 5% below its 50 day average. It is 5% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $171.67, and the nearest resistance the Pivot at $174.18.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 3.9%/day
Key levels
$247.4952 week high+43.0%
$194.93100 day average+12.6%
$183.3720 day average+6.0%
$182.53Swing high (Aug 28)+5.5%
$182.3150 day average+5.3%
$181.54200 day average+4.9%
$175.58Pivot R1+1.5%
$174.18Pivot+0.6%
$173.07Last close
$171.67Pivot S1−0.8%
$171.40Swing low (Aug 24)−1.0%
$101.0052 week low−41.6%
Indicators
RSI (14)40.78Middle of its rangeNeutral
MACD-2.00Below its signal lineBearish
Stochastic10.6Near the bottom of its rangeOversold
ADX (14)13.4No clear trend
Williams %R-92.6Oversold below −80, overbought above −20Oversold
CCI (20)-126.9Oversold below −100, overbought above 100Oversold
Rate of change−5.0%Change over 10 sessionsBearish
ATR (14)$6.70Typical daily range, 3.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for DVA

What happened before

See how DVA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bearish1 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow DVA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How DVA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
4
Bullish
1
25%
Bearish
3
75%
Date span
Aug 25 – Nov 5
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
3
Notional
$2.1M
Largest print
$915K
Loading…

DVA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲328 buying vs 262 selling
  • ▲Held by funds +1.5 pts
  • ▼Funds holding -14
  • ▼Superinvestors: 2 added, 4 cut
  • ▲Put/call 0.37 to 0.24
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding621635−2.2%
In funds' top 1002−100.0%
Held by funds95.7%94.2%+1.5 pts
New / increased84 / 244116 / 187+8.3%
Reduced / sold out172 / 90222 / 69−10.0%
Put/call ratio0.240.37−36.6%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See DVA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

DVA Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$725.3M
6.7% yield
Left in program
$1.3B
11.9% of value
Shares outstanding, 12 months
−10.9%
Fewer shares
Last quarter
$78.7M
Sep 2026
Avg price paid, last quarter
$190.01
594K shares bought
S&P 500 rank by spending
#236 of 358
 
Spent each quarter, last 3 yearsTop bar $789.4M
Dec 2023: $284.1M, average price $97.82Mar 2024: $238.9M, average price $112.75Jun 2024: $372.1M, average price $140.14Sep 2024: $402.4M, average price $147.20Dec 2024: $766.2M, average price $147.56Mar 2025: $545.2M, average price $148.95Jun 2025: $441.7M, average price $144.00Sep 2025: $460.6M, average price $140.67Dec 2025: $789.4M, average price $136.49Mar 2026: $401.8M, average price $133.71Jun 2026: $346.8M, average price $154.96Sep 2026: $78.7M, average price $190.01
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DVA is in one of them and how their past DVA trades turned out.

DVA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DVA in an article yet. Here's the latest on the wider market.

DVA Congress Trades

All congress trades →
Trades, 12 months
4
Buys
3
75%
Sells
1
25%
People
3
Last filed Aug 5
Who traded DVA · since 2018
Latest 5 filings of 21
$1K – $15KTraded Sep 23, 2025Filed Aug 5, 2026
$1K – $15KTraded Sep 23, 2025Filed Aug 5, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded Jan 29, 2026Filed Feb 6, 2026
$1K – $15KTraded Sep 25, 2025Filed Oct 7, 2025
PersonTypeAmountTradedFiledDelay
Julie JohnsonD · TXBuy$1K – $15KSep 23, 2025Aug 5, 2026316 d
Julie JohnsonD · TXSell$1K – $15KSep 23, 2025Aug 5, 2026316 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Ro KhannaD · CABuy$1K – $15KJan 29, 2026Feb 6, 20268 d
Julie JohnsonD · TXSell$1K – $15KSep 25, 2025Oct 7, 202512 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Davita

DaVita is a healthcare company that provides kidney care, with a focus on patients who have kidney failure. Its largest business runs dialysis treatment centers in the United States, where machines filter waste and extra fluid from patients' blood. The company also offers care management for patients with complex chronic kidney disease and provides dialysis services in other countries. It is based in Denver, Colorado.

Headquarters
Denver, CO
Founded
1994